MedTrace Logo

Family Meeting Study for End Stage Renal Disease

NCT02504021 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 120

Last updated 2017-09-19

No results posted yet for this study

Summary

A randomized clinical trial for patients with end stage renal disease in which a family consultation condition is compared against a treatment as usual control condition on the hospital readmissions after 1 month as the primary outcome variable.

Conditions

  • End-stage Renal Disease

Interventions

BEHAVIORAL

Family Consultation

This intervention is based on psychoeducation, social support mobilization, and motivational interviewing techniques.

Sponsors & Collaborators

  • Henry Ford Health System

    collaborator OTHER

  • Mark A. Lumley

    lead OTHER

Principal Investigators

  • Mark W Ketterer, Ph.D. · Henry Ford Health Systems

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2015-07-31
Primary Completion
2016-05-31
Completion
2016-10-31

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02504021 on ClinicalTrials.gov